FDA Approves Drug For Type 1 Diabetes

Teplizumab (Tzield) targets the autoimmune issues that drive the disease, rather than its symptoms, making the medication a game changer. “Today’s approval of a first-in-class therapy adds an important new…

Understanding Type 2 Diabetes

This animation describes insulin resistance, an underlying cause of type 2 diabetes. It explains the roles of glucose and the hormone insulin in our body. Symptoms of diabetes are reviewed…